Kolon TissueGene, Inc.

Languages

  • English
  • Korean
  • English
  • About
    • Overview
    • History
    • Management Team
    • Board of Directors
    • Advisory Boards
  • Technology
    • Overview
    • TG-C
    • Publications
  • Product Pipeline
    • Overview
    • Applications
  • Clinical Trials
  • IR
    • Stock Data
    • PR
    • IR Material
    • Disclosure
    • Analyst Report
  • Partnering/Alliances
  • Contact

Analyst Report

IR

IR

  • Stock Data
  • PR
  • IR Material
  • Disclosure
  • Analyst Report
Kolon TissueGene, Invossa Could Be Osteoarthritis Game-Changer

Kolon TissueGene, Invossa Could Be Osteoarthritis Game-Changer

Sep 26, 2017

Company: Samsung Securities
Analyst: Brian Lee

  • « Previous
  • 1
  • 2
  • 3
© 2025 Kolon TissueGene, Inc. All Rights Reserved.

This information—including product information—is intended only for residents of the United States. The products discussed on this site may have different labeling in different countries.

Privacy Policy Disclaimer Sitemap Ethical Management